Pregled bibliografske jedinice broj: 193842
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study // International journal of radiation oncology, biology, physics, 61 (2005), 824-829 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 193842 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study
Autori
Vrdoljak, Eduard ; Prskalo, Tomislav ; Omrčen, Tomislav ; Šitum, Kristina ; Boraska, Tihana ; Frleta Ilić, Nives ; Janković, Stipan ; Hamm, Wolfgang
Izvornik
International journal of radiation oncology, biology, physics (0360-3016) 61
(2005);
824-829
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
chemobrachytherapy; squamous cell carcinoma; cisplatin; cervix; ifosfamide
Sažetak
Purpose: To evaluate the efficacy and toxicity of ifosfamide and cisplatin administered concomitantly with low-dose-rate brachytherapy followed by consolidation chemotherapy in the treatment of locally advanced squamous cell cervical carcinoma (LASCC). Methods and Materials: Forty-four patients with biopsy-proven LASCC were enrolled. FIGO Stages 1132 bulky to IVA were entered into this study. Patients were assigned to receive external radiotherapy (50 Gy in 25 fractions) ; then ifosfamide 2 g/m(2) Plus cisplatin 75 mg/m(2) was applied during two low-dose-rate brachytherapy applications, and 4 cycles of consolidation chemotherapy with the same drug combination were given after completion of radiotherapy. The planned dose to point A was 85 Gy. Results: All patients received both courses of concomitant chemobrachytherapy and at least 1 cycle of consolidation chemotherapy. The average duration of radiation was 45.1 days. The clinical complete response rate was 100%. Grade 3 and 4 leukopenia occurred in 25 % and 11% of the cycles, respectively. After a median follow-up of 34 months (range, 20-54 months), the recurrence-free and the overall survival rates were 84% and 91%, respectively. Major delayed local complications occurred in 7 cases (16%). Conclusions: These results indicate that concomitant chemobrachyradiotherapy with ifosfamide and cisplatin is a feasible combination for patients with LASCC of the cervix uteri. A randomized trial is planned.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
KBC Split
Profili:
Ante Omrčen
(autor)
Eduard Vrdoljak
(autor)
Tihana Boraska Jelavić
(autor)
Stipan Janković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE